Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Journal of Translational Medicine
|
April 8, 2021
The "Great Debate" at Immunotherapy Bridge 2020, December 3rd, 2020
Paolo A Ascierto, Joshua Brody, Lisa H Butterfield, et al.
Blood Advances
|
May 8, 2020
Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies
Stephen M Ansell, Ian Flinn, Matthew H Taylor, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 25, 2021
Current strategies for intratumoural immunotherapy - Beyond immune checkpoint inhibition
Jianda Yuan, Anuradha Khilnani, Joshua Brody, et al.
Blood
|
April 5, 2018
SOX11 augments BCR signaling to drive MCL-like tumor development
Pei-Yu Kuo, Shashidhar S Jatiani, Adeeb H Rahman, et al.
Blood
|
April 27, 2016
A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells
Xiaoli Wang, David Haylock, Cing Siang Hu, et al.
Journal for Immunotherapy of Cancer
|
December 28, 2020
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma
Sattva S Neelapu, Sherry Adkins, Stephen M Ansell, et al.
Blood
|
January 9, 2013
High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells
June H Myklebust, Jonathan M Irish, Joshua Brody, et al.
Plos Genetics
|
August 23, 2013
β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors
Luca Grumolato, Guizhong Liu, Tomomi Haremaki, et al.
Cancer Research
|
February 14, 2016
Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma
Deepak Perumal, Pei-Yu Kuo, Violetta V Leshchenko, et al.
Blood
|
December 25, 2016
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling
June H Myklebust, Joshua Brody, Holbrook E Kohrt, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Journal of Translational Medicine
|
April 8, 2021
The "Great Debate" at Immunotherapy Bridge 2020, December 3rd, 2020
Paolo A Ascierto, Joshua Brody, Lisa H Butterfield, et al.
Blood Advances
|
May 8, 2020
Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies
Stephen M Ansell, Ian Flinn, Matthew H Taylor, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 25, 2021
Current strategies for intratumoural immunotherapy - Beyond immune checkpoint inhibition
Jianda Yuan, Anuradha Khilnani, Joshua Brody, et al.
Blood
|
April 5, 2018
SOX11 augments BCR signaling to drive MCL-like tumor development
Pei-Yu Kuo, Shashidhar S Jatiani, Adeeb H Rahman, et al.
Blood
|
April 27, 2016
A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells
Xiaoli Wang, David Haylock, Cing Siang Hu, et al.
Journal for Immunotherapy of Cancer
|
December 28, 2020
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma
Sattva S Neelapu, Sherry Adkins, Stephen M Ansell, et al.
Blood
|
January 9, 2013
High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells
June H Myklebust, Jonathan M Irish, Joshua Brody, et al.
Plos Genetics
|
August 23, 2013
β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors
Luca Grumolato, Guizhong Liu, Tomomi Haremaki, et al.
Cancer Research
|
February 14, 2016
Dual Targeting of CDK4 and ARK5 Using a Novel Kinase Inhibitor ON123300 Exerts Potent Anticancer Activity against Multiple Myeloma
Deepak Perumal, Pei-Yu Kuo, Violetta V Leshchenko, et al.
Blood
|
December 25, 2016
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling
June H Myklebust, Joshua Brody, Holbrook E Kohrt, et al.
Page
of 5